GSK-7975A
GSK-7975A is a potent and orally available CRAC channel inhibitor.
Product Specifications
CAS Number
1253186-56-9
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/GSK-7975A.html
Concentration
10mM
Purity
99.83
Solubility
DMSO : ≥ 90 mg/mL
Smiles
O=C(NC1=NN(CC2=CC=C(O)C=C2C(F)(F)F)C=C1)C3=C(F)C=CC=C3F
Molecular Formula
C18H12F5N3O2
Molecular Weight
397.30
Precautions
H302, H315, H319, H335
References & Citations
[1]Ashmole I, et al. CRACM/Orai ion channel expression and function in human lung mast cells. J Allergy Clin Immunol. 2012 Jun;129 (6) :1628-35.e2.|[2]Rice LV, et al. Characterization of selective Calcium-Release Activated Calcium channel blockers in mast cells and T-cells from human, rat, mouse and guinea-pig preparations. Eur J Pharmacol. 2013 Mar 15;704 (1-3) :49-57.|[3]Wen L, et al. Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse Models. Gastroenterology. 2015 Aug;149 (2) :481-92.e7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PR2110-S 1 Each
Accuris qMAX First Strand cDNA Synthesis Flex Kit, sample, 5 reactions
Sign In for Pricing
View Details 
